Citigroup Inc Immutep LTD Call Options Transaction History
Citigroup Inc
- $217 Billion
- Q3 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding IMMP
# of Institutions
37Shares Held
2.35MCall Options Held
1.28KPut Options Held
20K-
Black Rock Inc. New York, NY839KShares$1.56 Million0.0% of portfolio
-
Meridian Wealth Management, LLC421KShares$782,8740.03% of portfolio
-
Sender CO & Partners, Inc. New York, NY216KShares$401,5010.13% of portfolio
-
Morgan Stanley New York, NY166KShares$308,6960.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA95.3KShares$177,1720.0% of portfolio
About IMMUTEP Ltd
- Ticker IMMP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 86,624,000
- Market Cap $161M
- Description
- Immutep Limited, a biotechnology company, engages in the research and development of pharmaceutical product candidates. The company develops immunotherapeutic products for the treatment of cancer and autoimmune diseases. Its lead product candidate is eftilagimod alpha (efti or IMP321), a recombinant protein that is in Phase IIb clinical trial as...